{
    "root": "8df39b9c-af70-4ac3-ba9f-6e8e795ba961",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "CELECOXIB",
    "value": "20250312",
    "ingredients": [
        {
            "name": "CELECOXIB",
            "code": "JCX84Q7J1L"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "POVIDONE",
            "code": "FZ989GH94E"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L"
        }
    ],
    "indications": "celecoxib non-steroidal anti-inflammatory indicated : osteoarthritis ( oa ) ( 1.1 ) rheumatoid arthritis ( rheumatoid arthritis ) ( 1.2 ) juvenile rheumatoid arthritis ( jra ) patients 2 years older ( 1.3 ) ankylosing spondylitis ( ) ( 1.4 ) acute pain ( ap ) ( 1.5 ) primary dysmenorrhea ( pd ) ( 1.6 )",
    "contraindications": "lowest effective shortest duration consistent individual patient treatment goals . ( 2.1 ) oa : 200 mg daily 100 mg twice daily . ( 2.2 , 14.1 ) rheumatoid arthritis : 100 mg 200 mg twice daily . ( 2.3 , 14.2 ) jra : 50 mg twice daily patients 10 kg 25 kg . 100 mg twice daily patients 25 kg . ( 2.4 , 14.3 ) : 200 mg daily single dose 100 mg twice daily . effect observed 6 weeks , trial 400 mg ( single divided doses ) may benefit . ( 2.5 , 14.4 ) ap pd : 400 mg initially , followed 200 mg dose needed first day . subsequent days , 200 mg twice daily needed . ( 2.6 , 14.5 ) hepatic impairment : reduce daily dose 50 % patients moderate hepatic impairment ( child-pugh class b ) . ( 2.7 , 8.6 , 12.3 ) poor metabolizers cyp2c9 substrates : consider dose reduction 50 % ( alternative management jra ) patients known suspected cyp2c9 poor metabolizers , ( 2.7 , 8.8 , 12.3 ) .",
    "warningsAndPrecautions": "celecoxib capsules available following strengths configurations : product name description size ndc number celecoxib capsules 50 mg white white colored granules filled size 2 hard gelatin white capsule , axially printed 'cipla ' cap & '423 ' '50 mg ' body red ink . bottle 30 capsules bottle 60 capsules 69097-423-02 69097-423-03 celecoxib capsules 100 mg white white colored granules filled size 2 hard gelatin white capsule , axially printed 'cipla ' cap & '422 ' '100 mg ' body blue ink . bottle 30 capsules bottle 100 capsules bottle 500 capsules 10 's blister carton 100 ( 10 x 10 ) unit- dose capsules 69097-422-02 69097-422-07 69097-422-12 69097-422-19 69097-422-21 celecoxib capsules 200 mg white white colored granules filled size 1 hard gelatin white capsule , axially printed 'cipla ' cap & '421 ' '200 mg ' body gold ink . bottle 30 capsules bottle 100 capsules bottle 500 capsules 10 's blister carton 100 ( 10 x 10 ) unit- dose capsules 69097-421-02 69097-421-07 69097-421-12 69097-421-19 69097-421-21 celecoxib capsules 400 mg white white colored granules filled size 0el hard gelatin white capsule , axially printed 'cipla ' cap & '420 ' '400 mg ' body green ink . bottle 30 capsules bottle 60 capsules bottle 480 capsules 10 's blister carton 100 ( 10 x 10 ) unit- dose capsules 69097-420-02 69097-420-03 69097-420-11 69097-420-19 69097-420-21 storage : store 25°c ( 77°f ) excursions permitted 15°c 30°c ( 59°f 86°f ) [ usp controlled room temperature ] .",
    "adverseReactions": "known hypersensitivity celecoxib , components product sulfonamides . ( 4 ) history asthma , urticaria , allergic-type taking aspirin nsaids . ( 4 ) setting cabg surgery . ( 4 )",
    "indications_original": "Celecoxib is a non-steroidal anti-inflammatory drug indicated for: Osteoarthritis (OA) ( 1.1 ) Rheumatoid Arthritis (RA) ( 1.2 ) Juvenile Rheumatoid Arthritis (JRA) in      patients 2 years and older ( 1.3 ) Ankylosing Spondylitis (AS) ( 1.4 ) Acute Pain (AP) ( 1.5 ) Primary Dysmenorrhea (PD) ( 1.6 )",
    "contraindications_original": "Use the lowest effective dosage for shortest duration consistent with individual patient treatment goals. ( 2.1 ) OA: 200 mg once daily or 100 mg twice daily. ( 2.2 , 14.1 ) RA: 100 mg to 200 mg twice daily. ( 2.3 , 14.2 ) JRA: 50 mg twice daily in patients 10 kg to 25 kg. 100 mg twice daily in patients more than 25 kg. ( 2.4 , 14.3 ) AS: 200 mg once daily single dose or 100 mg twice daily. If no effect is observed after 6 weeks, a trial of 400 mg (single or divided doses) may be of benefit. ( 2.5 , 14.4 ) AP and PD: 400 mg initially, followed by 200 mg dose if needed on first day. On subsequent days, 200 mg twice daily as needed. ( 2.6 , 14.5 ) Hepatic Impairment: Reduce daily dose by 50% in patients with moderate hepatic impairment (Child-Pugh Class B). ( 2.7 , 8.6 , 12.3 ) Poor Metabolizers of CYP2C9 Substrates: Consider a dose reduction by 50% (or alternative management for JRA) in patients who are known or suspected to be CYP2C9 poor metabolizers, ( 2.7 , 8.8 , 12.3 ).",
    "warningsAndPrecautions_original": "Celecoxib Capsules are available in the following strengths and configurations:\n                  \n                     \n                     \n                     \n                     \n                     \n                        \n                           \n                               Product Name\n                              \n                           \n                           \n                               Description\n                              \n                           \n                           \n                               Size\n                              \n                           \n                           \n                               NDC number\n                              \n                           \n                        \n                        \n                            Celecoxib Capsules 50 mg\n                           \n                            White to off white colored granules filled in size 2 hard gelatin white capsule,  axially printed with 'Cipla' on cap & '423' over '50 mg' on body in red ink.\n                           \n                            Bottle of 30 capsules Bottle of 60 capsules\n                           \n                            69097-423-02 69097-423-03\n                           \n                        \n                        \n                            Celecoxib Capsules 100 mg\n                           \n                            White to off white colored granules filled in size 2 hard gelatin white capsule,  axially printed with 'Cipla' on cap & '422' over '100 mg' on body in blue ink.\n                           \n                            Bottle of 30 capsules Bottle of 100 capsules Bottle of 500 capsules 10's Blister Carton of 100 (10 x 10) Unit- dose Capsules\n                           \n                            69097-422-02 69097-422-07 69097-422-12 69097-422-19 69097-422-21\n                           \n                        \n                        \n                            Celecoxib Capsules 200 mg\n                           \n                            White to off white colored granules filled in size 1 hard gelatin white capsule,  axially printed with 'Cipla' on cap & '421' over '200 mg' on body in gold ink.\n                           \n                            Bottle of 30 capsules Bottle of 100 capsules Bottle of 500 capsules 10's Blister Carton of 100 (10 x 10) Unit- dose Capsules\n                           \n                            69097-421-02 69097-421-07 69097-421-12 69097-421-19 69097-421-21\n                           \n                        \n                        \n                            Celecoxib Capsules 400 mg\n                           \n                            White to off white colored granules filled in size 0el hard gelatin white capsule,  axially printed with 'Cipla' on cap & '420' over '400 mg' on body in green ink.\n                           \n                            Bottle of 30 capsules Bottle of 60 capsules Bottle of 480 capsules 10's Blister Carton of 100 (10 x 10) Unit- dose Capsules\n                           \n                            69097-420-02 69097-420-03 69097-420-11 69097-420-19 69097-420-21\n                           \n                        \n                     \n                  \n                  \n                     \n                        Storage:\n                      \n                  Store at 25°C (77°F) excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].",
    "adverseReactions_original": "Known hypersensitivity to celecoxib, or any components of the drug product or sulfonamides. ( 4 ) History of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. ( 4 ) In the setting of CABG surgery. ( 4 )"
}